Acceleron Pharma reported $31.06M in Selling and Administration Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.84B 389M
Acceleron Pharma XLRN:US $ 31.06M 4.85M
Akebia Therapeutics AKBA:US $ 41.33M 1.02M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.25B 519M
Arena Pharmaceuticals ARNA:US $ 29.46M 5.44M
Bayer BAYN:GR 3.52B 30M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 86.87M 9.9M
Clovis Oncology CLVS:US $ 29.94M 10.82M
Dicerna Pharmaceuticals DRNA:US $ 20.67M 2.09M
Eli Lilly And LLY:US $ 1.58B 22.1M
Exelixis EXEL:US $ 102.35M 19.91M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 37.65M 3.72M
Mirati Therapeutics MRTX:US $ 28.35M 3.01M
Neurocrine Biosciences NBIX:US $ 129M 22.5M
Novartis NOVN:VX 3.52B 388M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 137.76M 76.66M
Puma Biotechnology PBYI:US $ 28.24M 368K
Regeneron Pharmaceuticals REGN:US $ 405.6M 102.1M
Rigel Pharmaceuticals RIGL:US $ 22.12M 303K
Sangamo Biosciences SGMO:US $ 16.15M 726K
Tg Therapeutics TGTX:US $ 26.76M 17.1M
Ultragenyx Pharmaceutical RARE:US $ 53.26M 2.22M
United Therapeutics UTHR:US $ 115.7M 43M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M